Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson's disease?
about
Neurophysiological biomarkers for Lewy body dementiasBiomarkers for dementia and mild cognitive impairment in Parkinson's disease.A combined TMS-EEG study of short-latency afferent inhibition in the motor and dorsolateral prefrontal cortex.Attentional Control of Gait and Falls: Is Cholinergic Dysfunction a Common Substrate in the Elderly and Parkinson's Disease?Impaired Pain Processing Correlates with Cognitive Impairment in Parkinson's Disease.Cholinergic dysfunction in Parkinson's disease.What can biomarkers tell us about cognition in Parkinson's disease?Modulation of Cortical Inhibitory Circuits after Cathodal Transcranial Direct Current Stimulation over the Primary Motor Cortex.Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal.Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline.Short-latency afferent inhibition determined by the sensory afferent volley.Short-latency afferent inhibition in patients with Parkinson's disease and freezing of gait.Modulation of Cerebellar-Cortical Connections in Multiple System Atrophy Type C by Cerebellar Repetitive Transcranial Magnetic Stimulation.Central cholinergic dysfunction could be associated with oropharyngeal dysphagia in early Parkinson's disease.Biomarker for mild cognitive impairment: is short latency afferent inhibition the answer?Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson's Disease?
P2860
Q26800048-6AA46B63-C102-4B86-B38E-819EA2B3547EQ31097119-03844B32-3A58-45FC-AA7E-9C342312464DQ36029880-467C8B1D-ED2D-4AD6-B337-A54E3C3EB3D2Q36881389-CAF27F0C-0015-4CD8-8F9A-7778FD9C1868Q37478879-D38FEFC7-29E4-4D16-892F-116E68ABF8B6Q37709932-6D8FBB0D-B028-478F-997F-948BC08D1D21Q38206497-D2292C23-C527-4E75-92F7-2165DDBDBF6FQ38255584-334E46AB-2A12-48E5-8C5A-394A39BFA6F9Q38643289-2A6F9D7E-77F1-484D-AA3A-450E5D6448BDQ38961546-FF42A7C7-E5FA-432C-B148-CF58118D5F6FQ40377256-116F5CBF-0C75-47ED-9D1E-0A4718284B55Q40675464-196503FA-4798-4831-AAEC-2E1D756218D7Q47424278-3999481D-EF4F-4275-8311-7B837A144860Q50577703-DA2CB3D3-B0D1-480D-8D7B-F2FEC22AF1B5Q50753935-37D0970C-8303-48B8-BF19-7691A428A4A6Q52148333-243ECC9E-6211-4E12-AA47-05399FC2FC8A
P2860
Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson's disease?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Short latency afferent inhibit ...... irment in Parkinson's disease?
@en
Short latency afferent inhibit ...... irment in Parkinson's disease?
@nl
type
label
Short latency afferent inhibit ...... irment in Parkinson's disease?
@en
Short latency afferent inhibit ...... irment in Parkinson's disease?
@nl
prefLabel
Short latency afferent inhibit ...... irment in Parkinson's disease?
@en
Short latency afferent inhibit ...... irment in Parkinson's disease?
@nl
P2093
P2860
P50
P356
P1433
P1476
Short latency afferent inhibit ...... irment in Parkinson's disease?
@en
P2093
Brook Galna
Gordan W Duncan
Rachel David
Tien K Khoo
P2860
P304
P356
10.1002/MDS.25360
P407
P577
2013-02-28T00:00:00Z